发明名称 MYOSTATIN INHIBITION FOR ENHANCING MUSCLE AND/OR IMPROVING MUSCLE FUNCTION
摘要 <p>The present invention relates to methods for inhibiting myostatin, a regulator of muscle mass, for muscle enhancement (including inducing hypertrophy and/or hyperplasia) as well as improving muscle function (including decreasing atrophy and/or increasing endurance, force and/or strength). Some of the methods involve delivering genes to cells using gene delivery or other delivery techniques known in the art in order to inhibit myostatin. Examples of genes to be delivered are genes encoding proteins such as Follistatin, Follistatin-related gene-1 (FLRG-I), growth differentiation factor associated protein- 1 (GASP-I) and myostatin precursor propeptide. The genes can be delivered using, for example, a recombinant Adeno-associated virus (rAAV), lentivirus or equine-associated virus capable of infecting the cells. Following introduction, the genes are expressed in the cell body of the infected cell and the encoded proteins are secreted systemically. In other methods of the invention expression of proteins such as activin lib and myostatin is inhibited by oligonucleotide techniques to effect muscle enhancement. All the methods have applications in the treatment of musculoskeletal and neurodegenerative disorders among others, as well as enhancing muscle in livestock.</p>
申请公布号 EP2097095(A2) 申请公布日期 2009.09.09
申请号 EP20070864918 申请日期 2007.11.29
申请人 NATIONWIDE CHILDREN'S HOSPITAL 发明人 KASPAR, BRIAN K.;MENDELL, JERRY R.
分类号 A61K38/17;A61K38/18;A61K48/00;A61P21/00;C12N15/861 主分类号 A61K38/17
代理机构 代理人
主权项
地址
您可能感兴趣的专利